Allied CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Allied Corp.'s amended 10-K filing details its focus on Colombian cannabis production, commercial expansion, and strategic shifts away from US operations and clinical trials.
OTC.Pink
Allied Corp. reports its fiscal year 2024 results, highlighting a strategic shift towards international cannabis production and distribution, particularly in Colombia, while temporarily pausing other initiatives.